ScienceDaily PharmaceuticalsOriginal article
Scientists turn probiotic bacteria into tiny drug factories for pancreatic cancer
Phase 1positiveEngineered probiotic bacteriaPositive
AI Analysis
Summary
Scientists engineered probiotic bacteria to act as drug factories that infiltrate pancreatic tumors and stimulate anti-cancer immune responses in animal studies, with enhanced efficacy when combined with standard cancer treatments.
Clinical Trial Data
Phase
preclinical
Primary Endpoint
Met
Outcome Details
Engineered probiotic bacteria infiltrated pancreatic tumors, stimulated cancer-fighting immune cells, and slowed tumor growth in animal studies. Treatment showed improved efficacy when combined with chemotherapy, radiation, or immunotherapy.
Importance:5/10
Sentiment:
0.70
probiotic bacteriapancreatic cancerimmunotherapycombination therapypreclinical
Related Companies
Read the original article
Published by ScienceDaily Pharmaceuticals on August 19, 2026 12:10 PM